Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05319457 · ClinicalTrials.gov registry record · NA

Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures

A NA study of Lung Cancer, sponsored by University of North Dakota.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT05319457: Completed NA study of Lung Cancer, sponsored by University of North Dakota.

NCT05319457 is a NA study of Lung Cancer that has completed, run by University of North Dakota. The registered enrollment target is 130 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05319457, a NA study of Lung Cancer, has completed, sponsored by University of North Dakota.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a critical public health problem.

Conditions Studied

Interventions

  • OTHER The radon app
  • OTHER Print brochure

Study Locations (1)

North Dakota

  • University of North Dakota - Grand Forks

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2022-05-05
Est. Completion 2022-09-01
Phase NA

Sponsor

University of North Dakota

4 total trials

What the Registry Record Tells You About NCT05319457

The ClinicalTrials.gov registry entry for NCT05319457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University of North Dakota, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which The radon app is the first listed.

NCT05319457 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT05319457 about?

NCT05319457 is a clinical study titled "Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures". The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a cri...

What is the current status of trial NCT05319457?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-05-05. Estimated completion is 2022-09-01.

What conditions does trial NCT05319457 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT05319457?

The interventions under investigation include: The radon app (OTHER), Print brochure (OTHER).

Who is sponsoring clinical trial NCT05319457?

This trial is sponsored by University of North Dakota, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05319457 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.